FDA Inspection 1201246 — Rhode Island Blood Center, A Division Of New York Blood Center, Inc.
The FDA completed an inspection of Rhode Island Blood Center, A Division Of New York Blood Center, Inc. on Mar 7, 2023 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Providence, RI (United States)